Bringing together leading experts regarding kidney disease research and patient care, Field Notes is an engaging forum discussing the latest developments, innovations, and trends that seek to improve outcomes and quality of life for individuals living with chronic disease. Fresenius Medical Care North America is the premiere healthcare company focused on providing innovative products and the highest quality care to people with renal and other conditions.
In this episode, we talk to Felicia Speed, LMSW, Corporate Director of Social Work Services at Fresenius Medical Care North America, about Physician Burnout: the emotional and mental strain that comes with providing care in a time of crisis.
Dr. Ahmad Sharif, Senior Vice President and Chief Medical Information Officer at Fresenius Medical Care North America, discusses the important use of telehealth to safely treat patients during the COVID-19 era and what the future holds for virtual patient care when the pandemic ends.
Dr. Dugan Maddux, Vice President of Kidney Disease Initiatives for Fresenius Medical Care North America, joins Field Notes to discuss the consequences of food insecurity for people living with serious chronic conditions and the importance of medically tailored meals in treating kidney disease.
Len Usvyat, PhD, Vice President of Applied Advanced Analytics, joins Field Notes to explain how artificial intelligence is being used to provide better treatment for people with kidney disease by predicting potential outcomes and future health care needs.
As the COVID-19 pandemic continues, its impacts on the body continue to be understood. Dr. Ted Toffelmire, the Senior Director of Medical Affairs in Canada for Fresenius Medical Care North America, joins Field Notes to discuss a potential link between the devastating virus and acute kidney injury.
Listen to Field Notes, a podcast by FMCNA. This episode welcomes Dr. Laura Niklason, co-founder of Humacyte, as she talks about dialysis access improvements.
Listen to Field Notes, a podcast by FMCNA. Dr. Emel Hamilton joins us to share how FMCNA is improving kidney patient outcomes through information exchange.
Phaneth Keo, Vice President of the Medical Strategies for Innovative Therapies at FMCNA's Renal Therapies Group, joins Field Notes to discuss the science and process behind the groundbreaking emergency use authorizations by the FDA.
Gina Sharkey and Tana Waack join Field Notes to provide a behind-the-scenes look at the front-lines inside some of the hospitals hit hardest by COVID-19.
Chance Mysayphonh, PharmD, clinical pharmacist for Fresenius Medical Care North America, joins Field Notes to discuss how new monoclonal antibody therapies will be used in Fresenius Kidney Care centers to help fight COVID-19.
Dr. Frank Maddux, Global Chief Medical Officer, joins Field Notes to explain how a new initiative to build the world"™s largest renal-focused genomic registry will impact the future of kidney care for years to come.
Dr. Michael Anger, Chief Medical Officer of the Renal Therapies Group, joins Field Notes to discuss the methods used to prevent bone damage, preventing the need for additional and expensive therapies for patients.
Joe Turk, former president of NxStage Medical and current president of home and critical care therapies for FMCNA, joins Field Notes to discuss how the merger is helping evolve and grow technology for home dialysis and critical care.
Bridgette Chandler, a former dialysis and transplant patient, joins Field Notes to discuss her journey from home dialysis patient to home dialysis nurse with Fresenius Kidney Care. Â
Laura Kemper and Nate Elias discuss how Fresenius Medical Care procured and distributed COVID vaccines to ESRD patients in dialysis centers nationwide.
Kim Sonnen and Dr. George Hart discuss how InterwellHealth is advancing value-based models of care to improve the outcomes for patients with kidney failure.
Dr. Kam Kalantar, an expert in kidney diseases and epidemiology, joins Field Notes to help us better understand the importance of managing albumin levels.
Jeff Burbank, chief strategy and transformation officer discusses the barriers we need to overcome to transform kidney care into a home first treatment model.
Michelle Carver discusses our home dialysis digital training platform, with separate educational experiences for both peritoneal dialysis and home hemodialysis.
Dr. Michael Anger and Jeffrey Carr discuss the significant impact of linking genomic and clinical data of both CKD and ESRD participants to improve outcomes.
FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.
A third of hemodialysis patients suffer from moderate to severe pruritus (or itching). For some, this can result in constant, unrelenting itching. Dr. Dinesh Chatoth, Associate Chief Medical Officer and Chair of the Pharmacy and Therapeutics Committee at Fresenius Kidney Care, joins Field Notes to discuss the condition and explore the ways Korsuva, a new FDA-approved medication, can help patients.
Our goal as providers is to give our patients the absolute best care possible, and that means we continuously work to improve and measure the quality of care we provide. As we grow peritoneal dialysis, the care and treatment we provide patients should result in lower morbidity and the best outcomes. But to understand how to improve, we need to answer this question: How do we measure the quality of PD?
Dr. Alpana Pasricha of the Nephrology Specialists and Scott Ochs, Vice President of Home Therapies at Fresenius Kidney Care join Field Notes to discuss how we can increase the number of patients transitioning from in-center to home dialysis.
In this episode, Dr. Amaka Eneanya and Mignon Early discuss FMC's recent commitment to the Zero Health Gaps Pledge and its efforts to close gaps in care on an international level
Dr. Stefano Stuard and Dr. Volodymyr Novakivskyy join this episode to talk about how they prepared patients in Ukraine prior to the Russian invasion in February of 2022 and all the measures they have taken since then to provide life-saving care and accommodations for patients.
Dr. Charles Herzog and Dr. Christopher Chan join this episode of Field Notes to talk about the American Heart Association's recent statement explaining how home dialysis can improve a patient's cardiovascular health and how prescribing dialysis with heart health in mind can increase the chances for successful care plans for patients.
Tune into this episode of Field Notes to listen to Dr. Michael Kraus and Michelle Carver, Senior Vice President of Nursing and Clinical Services at Fresenius Kidney Care, discuss what we can do to improve CAPD Culture in the United States.
Dr. Michael Kraus, Dr. Dinesh Chatoth, and Derek Blankenship talk about how TCU is an excellent way to provide predialysis care to patients, one of the most important components in a patient's kidney care journey.
In this 48th episode of Field Notes, Dr. Michael Kraus discusses artificial intelligence and machine learning with Dr. Luca Neri and Caitlin Monaghan. This is a two part-series, with the first part covering artificial intelligence more generally and this second part diving deeper into artificial intelligence in medicine and nephrology.
In this episode, Dr. Michael Kraus discusses two excellent resources Fresenius Kidney Care provides for patients: The Kidney Care Community and Kidney Care Advocates.
Google Play and the Google Play logo are trademarks of Google LLC.
The Apple logo and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.